SCHEDULE I -- Condensed Financial Information of the Registrant

12 Months Ended

Dec. 31, 2016

Condensed Financial Information of Parent Company Only Disclosure [Abstract]

SCHEDULE I -- Condensed Financial Information of the Registrant

ENDO INTERNATIONAL PLC

CONDENSED BALANCE SHEETS (Parent Company Only)

DECEMBER 31, 2016 AND 2015

(In thousands)

	December 31, 2016		December 31, 2015
ASSETS
CURRENT ASSETS:
Cash and cash equivalents	$	1,576	$	1,535
Accounts receivable	—		139
Accounts receivable from subsidiaries	33,979		29,197
Prepaid expenses and other current assets	1,065		1,139
Total current assets	$	36,620	$	32,010
INVESTMENT IN SUBSIDIARIES	2,721,656		6,000,170
TOTAL ASSETS	$	2,758,276	$	6,032,180
LIABILITIES AND EQUITY
CURRENT LIABILITIES:
Accounts payable and accrued expenses	2,703		2,094
Payables to subsidiaries	29,266		37,338
Total current liabilities	$	31,969	$	39,432
PAYABLES TO SUBSIDIARIES	24,718		24,718
EQUITY:
Euro deferred shares	42		43
Ordinary shares	22		22
Other equity	2,701,525		5,967,965
Total equity	$	2,701,589	$	5,968,030
TOTAL LIABILITIES AND EQUITY	$	2,758,276	$	6,032,180

See Notes to Condensed Financial Information.

ENDO INTERNATIONAL PLC

CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (Parent Company Only)

YEARS ENDEDDECEMBER 31, 2016, 2015 AND 2014

(In thousands)

	2016			2015			2014
COSTS AND EXPENSES:
Selling, general and administrative	$	40,139		$	31,922		$	18,618
Acquisition-related and integration items	1,060			1,247			3,407
OPERATING LOSS	$	(41,199	)	$	(33,169	)	$	(22,025	)
OTHER EXPENSE, NET	8			127			31
LOSS BEFORE INCOME TAXES	$	(41,207	)	$	(33,296	)	$	(22,056	)
EQUITY IN NET LOSS OF SUBSIDIARIES	(3,305,859		)	(1,461,746		)	(699,263		)
NET LOSS	$	(3,347,066	)	$	(1,495,042	)	$	(721,319	)
OTHER COMPREHENSIVE INCOME (LOSS)	30,771			(256,213		)	(119,173		)
COMPREHENSIVE LOSS	$	(3,316,295	)	$	(1,751,255	)	$	(840,492	)

See Notes to Condensed Financial Information.

ENDO INTERNATIONAL PLC

CONDENSED STATEMENTS OF CASH FLOWS (Parent Company Only)

YEARS ENDEDDECEMBER 31, 2016, 2015 AND 2014

(In thousands)

	2016			2015			2014
NET CASH USED IN OPERATING ACTIVITIES	$	(45,181	)	$	(8,696	)	$	(25,591	)
INVESTING ACTIVITIES:
Investment in subsidiaries	—			(2,236,752		)	—
Proceeds from dividends	54,770			250,000			—
Net cash provided by (used in) investing activities	$	54,770		$	(1,986,752	)	$	—
FINANCING ACTIVITIES:
Payments of tax withholding for restricted shares	(11,500		)	(15,398		)	(3,607		)
Exercise of options	1,952			27,217			29,766
Repurchase of ordinary shares	—			(250,088		)	—
Issuance of ordinary shares	—			2,300,000			—
Payments related to the issuance of ordinary shares	—			(65,316		)	—
Net cash (used in) provided by financing activities	$	(9,548	)	$	1,996,415		$	26,159
NET INCREASE IN CASH AND CASH EQUIVALENTS	$	41		$	967		$	568
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	1,535			568			—
CASH AND CASH EQUIVALENTS, END OF PERIOD	$	1,576		$	1,535		$	568

See Notes to Condensed Financial Information.

ENDO INTERNATIONAL PLC

NOTES TO CONDENSED FINANCIAL STATEMENTS (Parent Company Only)

FOR THE YEARS ENDEDDECEMBER 31, 2016, 2015 AND 2014

NOTE 1. BASIS OF PRESENTATION

The accompanying Condensed Financial Statements of Endo International plc (referred to in these Condensed Financial Statements as the Parent Company) have been prepared on a parent-only basis. Under this basis of presentation, the Parent Company’s investments in its consolidated subsidiaries are presented under the equity method of accounting.

As of December 31 of each of the years presented in these Condensed Financial Statements, the Parent Company has intercompany balances with its equity method subsidiaries. Additionally, during each of the years presented in these Condensed Financial Statements, the Parent Company has engaged in transactions with its equity method subsidiaries. In connection with these transactions, there are frequent cash movements between the Parent Company and these subsidiaries, certain of which are structured and accounted for as dividends. Transactions between Endo International plc and its consolidated subsidiaries, which are eliminated in our Consolidated Financial Statements, are presented in these Condensed Financial Statements.

NOTE 2. DIVIDENDS RECEIVED

Endo International plc received dividends of $54.8 million and $250.0 million in 2016 and 2015, respectively, from its consolidated subsidiaries. Endo International plc received no dividends in 2014 from its consolidated subsidiaries.

NOTE 3. PAYABLE TO SUBSIDIARIES

On February 28, 2014, Endo International plc issued $24.7 million in aggregate principal amount of a non-interest bearing note to one of its equity method subsidiaries. The loan is due upon the earlier of the expiration date of five years from the issuance date or upon written demand by the subsidiary.

NOTE 4. GUARANTEES

In accordance with the provisions of Section 357 of the Companies Act 2014, the Parent Company has guaranteed the liabilities of certain of its Irish subsidiaries in respect of the year ended December 31, 2015 in order to avail of the exemption from the filing provisions under Section 347 of the Companies Act 2014. These Irish subsidiaries are Endo Ventures Limited and Endo DAC.

The Parent Company is also a guarantor on both Dublin leases at Minerva House and Simmonscourt House, respectively, both with an address at Simmonscourt Road, Dublin 4, Ireland.